How to Read a Mass Spectrometry Report for Peptides

Mass spectrometry (MS) is the primary analytical technique for confirming that a synthetic peptide has the correct molecular weight — and therefore the correct amino acid sequence. While HPLC measures purity (how much of the sample is the intended product versus impurities), mass spectrometry provides identity confirmation (whether the main component is actually the expected peptide). A peptide that passes HPLC purity testing but shows the wrong molecular weight on MS is the wrong compound, regardless of how pure it appears chromatographically.

Every reputable peptide vendor includes mass spectrometry data on the certificate of analysis (CoA). Understanding how to read this data allows researchers to independently verify that they received the correct peptide before investing time and resources in experiments. This guide explains the key features of peptide MS reports in practical terms, assuming no prior mass spectrometry expertise.

A mass spectrometer measures the mass-to-charge ratio (m/z) of ionized molecules. The peptide is first converted from a neutral molecule into a charged ion (the ionization step), then separated according to its m/z ratio in the mass analyzer, and finally detected to produce a mass spectrum — a plot of signal intensity (y-axis) versus m/z (x-axis). The position of the peak on the x-axis tells you the mass of the molecule; the height of the peak tells you the relative abundance.

For peptides, the observed m/z value is compared to the theoretical molecular weight calculated from the amino acid sequence. If the observed mass matches the theoretical mass (within the instrument's accuracy, typically plus or minus 0.1-1.0 Da depending on the instrument type), the peptide identity is confirmed. A mismatch indicates an error in synthesis (wrong amino acid, incomplete deprotection, truncation) or that the sample is not the expected peptide.

Electrospray ionization (ESI) is the most common ionization method for peptide MS in vendor CoA reports. ESI works by spraying a peptide solution through a charged capillary needle, producing a fine mist of charged droplets that evaporate to yield multiply-charged peptide ions. ESI produces ions with multiple charges ([M+2H]2+, [M+3H]3+, etc.), so the observed m/z values are lower than the actual molecular weight. The spectrum must be deconvoluted (mathematically converted) to determine the neutral molecular weight.

Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS is an alternative that produces predominantly singly-charged ions ([M+H]+), making spectra easier to interpret directly — the observed m/z value is approximately the molecular weight plus 1 Da (the mass of the added proton). MALDI-TOF is faster and more tolerant of salt contamination than ESI but provides lower mass accuracy for small peptides. Both methods are acceptable for peptide identity confirmation; the choice is typically determined by the vendor's available instrumentation.

The most important peak in a peptide mass spectrum is the molecular ion peak — the peak corresponding to the intact peptide molecule plus one or more protons. In MALDI spectra, this appears as [M+H]+ at a value approximately 1 Da above the theoretical molecular weight. In ESI spectra, you will see a series of peaks representing different charge states: [M+H]+, [M+2H]2+, [M+3H]3+, and so on. The multiply-charged peaks appear at m/z values of (M+1)/1, (M+2)/2, (M+3)/3, where M is the neutral molecular weight.

For example, a peptide with a theoretical molecular weight of 1,500 Da would show: [M+H]+ at m/z 1,501; [M+2H]2+ at m/z 751; [M+3H]3+ at m/z 501. Seeing multiple charge states that all point to the same neutral mass provides strong confirmation of the molecular weight. Software algorithms perform this deconvolution automatically, and the report typically shows both the raw spectrum and the deconvoluted (neutral) mass.

Multiply-charged ions are a hallmark of ESI-MS and initially confuse researchers unfamiliar with the technique. The key principle is that each charge state provides an independent measurement of the same molecular weight. To manually calculate the neutral mass from two adjacent charge state peaks: if peak 1 has m/z = m1 with charge z, and peak 2 has m/z = m2 with charge z+1, then M = z(m1 - m2)/(m2 - m1 - 1.008). In practice, deconvolution software handles this calculation automatically.

The deconvoluted spectrum (also called the zero-charge spectrum or MaxEnt spectrum) shows a single peak at the neutral molecular weight, stripping away the complexity of multiple charge states. This is the most useful representation for identity confirmation. The vendor CoA should report the deconvoluted molecular weight and compare it to the calculated theoretical value. A match within instrument accuracy (typically within 1 Da for standard instruments, within 0.1 Da for high-resolution instruments) confirms identity.

In addition to the protonated molecular ion, mass spectra frequently show adduct peaks — ions formed by association of the peptide with common cations present in the sample or solvent. Sodium adducts [M+Na]+ appear at M+23 Da, potassium adducts [M+K]+ at M+39 Da, and ammonium adducts [M+NH4]+ at M+18 Da. These adducts are normal and do not indicate impurities; they arise from trace salts in the sample or solvent and appear alongside the expected protonated species.

Trifluoroacetic acid (TFA), a common mobile phase additive used in HPLC purification, can form adducts at M+114 Da. Acetonitrile adducts appear at M+41 Da. Water loss peaks at M-18 Da may indicate partial dehydration during ionization (especially for peptides containing serine or threonine) or the presence of aspartimide degradation products. Recognizing these common artifacts prevents misinterpretation of the spectrum as evidence of impurities or incorrect identity.

To confirm peptide identity, compare the observed deconvoluted molecular weight with the theoretical value calculated from the sequence using the formula: MW = sum of residue weights + 18.015 (for the terminal water molecule). Online calculators are available for this computation. Agreement within 1 Da for standard-resolution instruments or within 0.5 Da for high-resolution instruments constitutes positive identity confirmation. Larger deviations require investigation.

Common causes of mass discrepancies include: missing or extra amino acids (each residue adds 57-186 Da depending on identity), incomplete removal of protecting groups (Boc = +100 Da, Fmoc = +222 Da, Pbf = +252 Da), oxidation of methionine (+16 Da), deamidation of asparagine (+1 Da), sodium adduct misidentified as the molecular ion (+22 Da), and TFA salt form versus acetate salt form (TFA counterion = 114 Da, acetate = 60 Da). Checking for these systematic offsets can explain apparent mass mismatches.

Missing MS data on the CoA is a significant red flag — identity verification is a fundamental quality control step, and its absence suggests either inadequate QC procedures or deliberate omission of unfavorable results. A reported mass that deviates from the theoretical value by more than 2 Da (on a standard instrument) without explanation warrants concern. Multiple peaks of comparable intensity in the deconvoluted spectrum suggest a mixture of peptides rather than a single pure product.

Reports that show only the raw (non-deconvoluted) ESI spectrum without interpretation leave the identity confirmation burden on the researcher. Vendors providing only a MALDI spectrum for a large peptide (above 5,000 Da) where ESI would provide superior accuracy may be using the less precise method to obscure mass discrepancies. The highest-quality CoAs include both the raw spectrum, the deconvoluted mass, the theoretical mass, and the mass deviation in Daltons.

• Fenn JB et al. (1989). Electrospray ionization for mass spectrometry of large biomolecules. Science, 246(4926):64-71.
• Karas M, Hillenkamp F (1988). Laser desorption ionization of proteins with molecular masses exceeding 10,000 Daltons. Anal Chem, 60(20):2299-2301.
• Dass C (2007). Fundamentals of Contemporary Mass Spectrometry. John Wiley & Sons.
• de Hoffmann E, Stroobant V (2007). Mass Spectrometry: Principles and Applications. 3rd ed. John Wiley & Sons.
• Mann M, Kelleher NL (2008). Precision proteomics: the case for high resolution. Proc Natl Acad Sci, 105(47):18132-18138.
• Siuzdak G (2006). The Expanding Role of Mass Spectrometry in Biotechnology. 2nd ed. MCC Press.
• Standing KG (2003). Peptide and protein de novo sequencing by mass spectrometry. Curr Opin Struct Biol, 13(5):595-601.

• Read more: What Is HPLC Purity? → https://www.chemverify.com/learn/what-is-hplc-purity-peptide-analysis
• Read more: How to Read a Certificate of Analysis for Peptides → https://www.chemverify.com/learn/how-to-read-certificate-of-analysis-peptides